Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$139K Buy
940
+60
+7% +$8.78K 0.01% 331
2025
Q4
$107K Buy
880
+720
+450% +$84.5K 0.01% 237
2025
Q3
$17.3K Hold
160
﹤0.01% 531
2025
Q2
$14.3K Sell
160
-130
-45% -$9.78K ﹤0.01% 540
2025
Q1
$19.7K Buy
290
+130
+81% +$9.36K ﹤0.01% 487
2024
Q4
$10.1K Hold
160
﹤0.01% 619
2024
Q3
$12.4K Hold
160
﹤0.01% 582
2024
Q2
$13.2K Hold
160
﹤0.01% 555
2024
Q1
$11.2K Hold
160
﹤0.01% 579
2023
Q4
$9.3K Hold
160
﹤0.01% 576
2023
Q3
$7.34K Hold
160
﹤0.01% 591
2023
Q2
$7.76K Hold
160
﹤0.01% 596
2023
Q1
$6.39K Hold
160
﹤0.01% 618
2022
Q4
$6.03K Hold
160
﹤0.01% 606
2022
Q3
$5K Hold
160
﹤0.01% 644
2022
Q2
$5K Hold
160
﹤0.01% 619
2022
Q1
$6K Hold
160
﹤0.01% 603
2021
Q4
$7K Hold
160
﹤0.01% 588
2021
Q3
$5K Hold
160
﹤0.01% 624
2021
Q2
$5K Hold
160
﹤0.01% 621
2021
Q1
$5K Buy
+160
New +$4.82K ﹤0.01% 591

Other funds holding KLAC

McIlrath & Eck's KLAC Position: Q1 2026 in Review

McIlrath & Eck increased its KLA (KLAC) stake by 6.8% in Q1 2026, buying an estimated $8.78K and bringing the position to 940 shares worth $139K. The position accounts for 0.01% of the portfolio, ranked #331.

McIlrath & Eck first reported a position in KLAC in Q1 2021 and has held it in 21 quarters since. 2,072 funds tracked by Wall St. Rank hold KLAC as of Q1 2026.

  • McIlrath & Eck held 940 shares of KLA worth $139K as of Q1 2026.
  • McIlrath & Eck bought 60 KLA shares in Q1 2026, an estimated $8.78K.
  • KLA made up 0.01% of McIlrath & Eck's portfolio in Q1 2026, its #331 holding.
  • McIlrath & Eck first reported a position in KLA in Q1 2021 and has held it in 21 quarters since.
  • 2,072 funds tracked by Wall St. Rank held KLA as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.